Q4 2024 Management View CEO Michel Brousset highlighted that 2024 was a transformative year for Waldencast, with strong performance from its brands, Milk Makeup and Obagi Medical, both significantly ...
TipRanks on MSN4d
Waldencast price target lowered to $3.40 from $4.30 at TD CowenTD Cowen lowered the firm’s price target on Waldencast (WALD) to $3.40 from $4.30 and keeps a Hold rating on the shares. The firm updated its ...
Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023FY 2024 Net ...
Waldencast ( NASDAQ:WALD ) Full Year 2024 Results Key Financial Results Revenue: US$273.9m (up 26% from FY 2023). Net... Waldencast PLC (WALD) reports robust revenue increases and secures a new ...
Waldencast (NASDAQ:WALD – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at DA Davidson in a ...
Waldencast reports Q4 2024 net revenue of $72.1 million, 29.4% growth, and $11.2 million adjusted EBITDA, doubling year-over-year. Net Loss decreased only slightly from $32.7 million in Q4 2023 to ...
LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced its ...
Telsey Advisory Group reiterated their outperform rating on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note published on Wednesday morning,Benzinga reports. Telsey Advisory Group ...
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on KULR Technology Group (KULR – Research Report) ...
Michel Brousset, Waldencast Founder and CEO, said: “We closed a transformative year for the Group, achieving outstanding growth, expanding our brands' communities, and making significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback